Company: LHI
Filing Date: 2025-11-20
Form Type: F-1/A
Source: 0001213900-25-112807
Chunk: 32

Company: Living Homeopathy International Ltd.
Filing Date: 2025-11-20
Form: F-1/A
Chunk 32
---
 poisoning involving a senior female
customer who allegedly had a history of consuming Living Colloidal, and reminds the public of not consuming products containing colloidal
silver. Our sales of LIVING Colloidal Silver were subject to our quality control procedure, comprising conducting certain sample testing
at Hong Kong STC. See “Business – Quality Control” on page 82 of this prospectus for further details. We immediately
terminated the sales of LIVING Colloidal Silver for human use. If any human consumption of LIVING Colloidal Silver results in silver
poisoning or other harmful side effects, consumers may bring legal actions against us for damages and regulators may bring investigations
or other proceedings against us which may result in our exposure to monetary and non-monetary penalties. If so, our reputation, business
growth, financial condition and results of operations will be materially and adversely affected. Even if we are found not at fault in
these legal actions or proceedings, we will have to put in substantial financial resources and managerial attention to deal with these
legal actions and proceedings, which otherwise can be applied toward our business development. As of the date of this prospectus, we
are not aware of any complaints, claims, regulator inquiries or legal proceeding relating to Living Colloidal Silver, which, however,
if occurs, will adversely affect our business, financial condition and results of operations. Any negative publicity on us or any of
our products could have a material adverse effect on our reputation and the sales of our products, which could further materially and
adversely affect our business, financial condition and results of operations.

Our business is heavily regulated and our industry may be subject to increasingly tightened regulatory requirements and scrutiny in the main markets where we operate and the new markets we will sell our products, which could potentially adversely affect our business growth, financial condition and results of operations.

As of the date of this prospectus, our primary
operations are based in Hong Kong. Our business is heavily regulated in Hong Kong and must comply with applicable laws and regulations,
including the need to obtain certain licenses and permits. For example, we are required to comply with the Food Safety Ordinance (Chapter
612 of the Laws of Hong Kong) and be registered as a food importer/distributor under the Food Safety to be able to import health supplements
into Hong Kong for sale. See “Regulations – Food Safety Ordinance (Chapter 612 of the Laws of Hong Kong)”
on page 84 of this prospectus. If we fail to obtain or